Polyoxovanadate inhibition of: Escherichia coli growth shows a reverse correlation with Ca2+-ATPase inhibition
| dc.contributor.author | Marques-Da-Silva, D. | |
| dc.contributor.author | Fraqueza, G. | |
| dc.contributor.author | Lagoa, R. | |
| dc.contributor.author | Anandan Vannathan, A.A. | |
| dc.contributor.author | Mal, S.S. | |
| dc.contributor.author | Aureliano, M. | |
| dc.date.accessioned | 2026-02-05T09:30:38Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | Recently, a global analysis of the structure-activity-relationship of a series of polyoxometalates (POMs) revealed that the most active POMs were ascribed to be polyoxovanadates (POVs), especially decavanadate (V<inf>10</inf>), which was very active against certain bacteria (Bijelic et al., Chem. Commun., 2018). The present study explores this observation and compares the effects of three POVs namely MnV<inf>11</inf>, MnV<inf>13</inf> and V<inf>10</inf> against Escherichia coli growth. It was observed that MnV<inf>11</inf> presents the lowest growth inhibition (GI<inf>50</inf>) value for Escherichia coli followed by the MnV<inf>13</inf> compound, being about 2 times lower than that of V<inf>10</inf>; respectively, the values obtained were 0.21, 0.27 and 0.58 mM. All three compounds were more effective than vanadate alone (GI<inf>50</inf> = 1.1 mM) and also than decaniobate, Nb<inf>10</inf> (GI<inf>50</inf> > 10 mM), an isostructural POM of V<inf>10</inf>. However, the POVs exhibiting the highest antibacterial activity (MnV<inf>11</inf>) were shown to have the lowest Ca2+-ATPase inhibitor capacity (IC<inf>50</inf> = 58 ?M) whereas decavanadate, which was also very active against this membranar ATPase (IC<inf>50</inf> = 15 ?M), was less active against bacterial growth, suggesting that POV inhibition of ion pumps might not be associated with the inhibition of Escherichia coli growth. This journal is © The Royal Society of Chemistry and the Centre National de la Recherche Scientifique. | |
| dc.identifier.citation | New Journal of Chemistry, 2019, 43, 45, pp. 17577-17587 | |
| dc.identifier.issn | 11440546 | |
| dc.identifier.uri | https://doi.org/10.1039/c9nj01208g | |
| dc.identifier.uri | https://idr.nitk.ac.in/handle/123456789/24803 | |
| dc.publisher | Royal Society of Chemistry | |
| dc.subject | adenosine triphosphatase (calcium) | |
| dc.subject | ammonium vanadate | |
| dc.subject | calcium ionophore | |
| dc.subject | decavanadate | |
| dc.subject | polyoxovanadate | |
| dc.subject | sarcoplasmic reticulum calcium transporting adenosine triphosphatase | |
| dc.subject | unclassified drug | |
| dc.subject | vanadic acid | |
| dc.subject | antibacterial activity | |
| dc.subject | Article | |
| dc.subject | calcium homeostasis | |
| dc.subject | cell culture | |
| dc.subject | controlled study | |
| dc.subject | densitometry | |
| dc.subject | depolymerization | |
| dc.subject | drug decomposition | |
| dc.subject | drug potency | |
| dc.subject | drug solubility | |
| dc.subject | enzyme activity | |
| dc.subject | enzyme inhibition | |
| dc.subject | Escherichia coli | |
| dc.subject | GI50 | |
| dc.subject | Helicobacter pylori | |
| dc.subject | IC50 | |
| dc.subject | nonhuman | |
| dc.subject | optical density | |
| dc.subject | polyacrylamide gel electrophoresis | |
| dc.subject | protein synthesis inhibition | |
| dc.subject | sarcoplasmic reticulum | |
| dc.subject | solubilization | |
| dc.subject | Streptococcus pneumoniae | |
| dc.subject | structure activity relation | |
| dc.subject | turbidity | |
| dc.subject | ultraviolet visible spectroscopy | |
| dc.title | Polyoxovanadate inhibition of: Escherichia coli growth shows a reverse correlation with Ca2+-ATPase inhibition |
